ORMP
ORAMED PHARMACEUTICALS INC.
Key Financials
Gross Profit
$13000
N/A
Revenue
$2.0M
↑ 49.3%
Operating Income
$-15088000
↓ 18.1%
Net Income
$64.0M
↑ 435.3%
Total Assets
$230.9M
↑ 48.7%
EPS (Diluted)
$1.50
↑ 412.5%
Total Liabilities
$502688.00
N/A
Shareholders' Equity
$199.7M
↑ 36.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/2/2026 | View on SEC |
| 4 | 10/2/2026 | View on SEC |
| 144 | 10/1/2026 | View on SEC |
| 144 | 10/1/2026 | View on SEC |
| 4 | 9/25/2026 | View on SEC |
| 4 | 9/25/2026 | View on SEC |
| 4 | 9/25/2026 | View on SEC |
| 4 | 9/25/2026 | View on SEC |
| 8-K | 9/17/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ORMP |
| Company Name | ORAMED PHARMACEUTICALS INC. |
| CIK | 1176309 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 646-844-1164 |